R2 change | β | p Value | |
---|---|---|---|
TtP | |||
Step 1* | 0.18 | <0.01 | |
Step 2 | 0.02 | 0.15 | |
Duration | −0.05 | 0.60 | |
Age* | −0.41 | <0.01 | |
Gender | 0.002 | 0.98 | |
RMS-SD | −0.14 | 0.15 | |
P%BL | |||
Step 1 | 0.06 | 0.12 | |
Step 2 | 0.006 | 0.45 | |
Duration | −0.16 | 0.14 | |
Age* | 0.22 | 0.04 | |
Gender | −0.03 | 0.75 | |
RMS-SD | 0.08 | 0.45 | |
TtP | |||
Step 1* | 0.18 | <0.01 | |
Step 2 | 0.02 | 0.13 | |
Duration | −0.06 | 0.56 | |
Age* | −0.41 | <0.01 | |
Gender | 0.01 | 0.90 | |
SDNN | −0.15 | 0.13 | |
P%BL | |||
Step 1 | 0.06 | 0.12 | |
Step 2 | 0.005 | 0.48 | |
Duration | −0.15 | 0.15 | |
Age* | 0.22 | 0.04 | |
Gender | −0.04 | 0.70 | |
SDNN | 0.07 | 0.48 | |
TtP | |||
Step 1* | 0.18 | <0.01 | |
Step 2 | 0.001 | 0.76 | |
Duration | −0.04 | 0.67 | |
Age* | −0.41 | <0.01 | |
Gender | 0.01 | 0.89 | |
Total power | −0.03 | 0.76 | |
P%BL | |||
Step 1 | 0.06 | 0.12 | |
Step 2 | 0.001 | 0.83 | |
Duration | −0.16 | 0.13 | |
Age* | 0.22 | 0.04 | |
Gender | −0.04 | 0.70 | |
Total power | 0.02 | 0.83 |
*Significant at p<0.05.
P%BL, peak as a percentage of baseline; PORH, postocclusive reactive hyperemia; RMS-SD, root mean square of the R–R interval; SDNN, SD of the N–N interval; TtP, time to peak.